Table 1.

Basic and demographic characteristics of patients in each study group

Variable	MMC (n=19)	5-Fu (n=18)	P-value
Age (years)	61.7 ± 18.9	48.4 ± 25.5	0.082†
Male sex [N(%)]	17 (89.5)	12 (66.7)	0.124‡
Baseline BCVA (LogMAR)	1.18 ± 0.64	0.82 ± 0.64	0.097†
Glaucoma subtype [N(%)]			0.192‡
POAG	5 (26.3)	2 (11.1)
PACG	7 (36.7)	5 (27.8)
Congenital	0 (0)	5 (27.8)
PXF	2 (10.5)	3 (16.7)
Uveitic	2 (10.5)	1 (5.6)
Pseudophakic	3 (15.8)	2 (11.1)
Previous surgeries (N)	1.0 ± 1.2	0.7 ± 1.0	0.443§
Duration of medications before surgery (years)	5.6 ± 7.2	6.0 ± 9.8	0.982§
Preoperative medications (N)	2.5 ± 0.7	3.2 ± 0.8	0.012§
Lens status [N(%)]			0.022*
Phakic	6 (31.6)	13 (72.2)
Pseudophakic	13 (68.4)	5 (27.8)
Preoperative IOP (mmHg)	20.6 ± 8.8	25.8 ± 11.4	0.129†
Cup/disc ratio	87.2 ± 13.6	83.1 ± 17.1	0.424†
Interval between surgery and trial (days)	7.9 ± 5.1	9.7 ± 5.6	0.265§
Type of operation [N(%)]			0.017‡
PT+PCIOL	11 (57.9)	3 (16.7)
Trabeculectomy	8 (42.1)	15 (83.3)

^†t-test;

^‡Fisher Exact test;

^§Mann-Whitney test;

^*chi-square test

MMC, mitomycin-C; 5-FU, 5-fluorouracil; N, number; BCVA, best-corrected visual acuity; POAG, primary open angle glaucoma; PACG, primary angle closure glaucoma; PXF, pseudoexfoliation; IOP, intraocular pressure; PT+PCIOL, combined phacoemulsification and trabeculectomy with posterior chamber intraocular lens implantation